OptimizeRx Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
OptimizeRx Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q2 2025.
  • OptimizeRx Corp Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2025 was $2.9M.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $2.9M Jun 30, 2025 10-Q 2025-08-08
Q1 2025 $2.9M Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $4.22M +$864K +25.7% Dec 31, 2024 10-K 2025-03-20
Q4 2023 $3.36M -$4.81M -58.9% Dec 31, 2023 10-K 2025-03-20
Q4 2022 $8.16M +$2.9M +55.1% Dec 31, 2022 10-K 2024-04-15
Q4 2021 $5.26M +$3.01M +133% Dec 31, 2021 10-K 2023-03-10
Q4 2020 $2.26M +$529K +30.6% Dec 31, 2020 10-K/A 2023-03-10
Q4 2019 $1.73M -$1.21M -41.2% Dec 31, 2019 10-K 2021-03-08
Q4 2018 $2.94M -$83K -2.75% Dec 31, 2018 10-K 2020-03-26
Q4 2017 $3.02M -$1.17M -27.8% Dec 31, 2017 10-K 2019-03-12
Q4 2016 $4.19M +$1.08M +34.6% Dec 31, 2016 10-K 2018-03-08
Q4 2015 $3.11M -$16K -0.51% Dec 31, 2015 10-K 2017-03-08
Q4 2014 $3.13M +$333K +11.9% Dec 31, 2014 10-K 2016-03-15
Q1 2014 $5M +$9.74M Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $2.79M +$7.53M Dec 31, 2013 10-K 2015-09-16
Q3 2013 -$4.62M +$129K +2.72% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 -$4.62M +$89K +1.89% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 -$4.74M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 -$4.74M -$155K -3.38% Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$4.75M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 -$4.71M Jun 30, 2012 10-Q 2012-08-14
Q4 2011 -$4.58M Dec 31, 2011 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.